You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Zydus Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS, and what generic and branded alternatives to ZYDUS PHARMS drugs are available?

ZYDUS PHARMS has two hundred and seventy-two approved drugs.

There are twenty-three tentative approvals on ZYDUS PHARMS drugs.

Summary for Zydus Pharms

US Patents:	0
Tradenames:	237
Ingredients:	228
NDAs:	272

Drugs and US Patents for Zydus Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Pharms	AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM	amlodipine besylate; atorvastatin calcium	TABLET;ORAL	207762-009	Jan 11, 2019	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Zydus Pharms	DOXYCYCLINE	doxycycline hyclate	INJECTABLE;INJECTION	207757-001	Sep 28, 2017	AP	RX	No	Yes		⤷ Sign Up				⤷ Sign Up
Zydus Pharms	ENOXAPARIN SODIUM (PRESERVATIVE FREE)	enoxaparin sodium	INJECTABLE;SUBCUTANEOUS	076726-004	Jun 23, 2014	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
Zydus Pharms Usa Inc	DIVALPROEX SODIUM	divalproex sodium	TABLET, DELAYED RELEASE;ORAL	077100-002	Mar 5, 2009	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Zydus Pharms	NIFEDIPINE	nifedipine	TABLET, EXTENDED RELEASE;ORAL	210012-002	Dec 19, 2017	AB2	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ZYDUS PHARMS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.